1. Home
  2. MNOV vs SNAL Comparison

MNOV vs SNAL Comparison

Compare MNOV & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • SNAL
  • Stock Information
  • Founded
  • MNOV 2000
  • SNAL 2000
  • Country
  • MNOV United States
  • SNAL United States
  • Employees
  • MNOV N/A
  • SNAL N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • SNAL Computer Software: Prepackaged Software
  • Sector
  • MNOV Health Care
  • SNAL Technology
  • Exchange
  • MNOV Nasdaq
  • SNAL Nasdaq
  • Market Cap
  • MNOV 91.7M
  • SNAL 92.8M
  • IPO Year
  • MNOV 2005
  • SNAL 2022
  • Fundamental
  • Price
  • MNOV $1.97
  • SNAL $2.72
  • Analyst Decision
  • MNOV Strong Buy
  • SNAL
  • Analyst Count
  • MNOV 1
  • SNAL 0
  • Target Price
  • MNOV $9.00
  • SNAL N/A
  • AVG Volume (30 Days)
  • MNOV 18.0K
  • SNAL 146.8K
  • Earning Date
  • MNOV 02-25-2025
  • SNAL 03-31-2025
  • Dividend Yield
  • MNOV N/A
  • SNAL N/A
  • EPS Growth
  • MNOV N/A
  • SNAL N/A
  • EPS
  • MNOV N/A
  • SNAL 0.08
  • Revenue
  • MNOV N/A
  • SNAL $86,822,973.00
  • Revenue This Year
  • MNOV N/A
  • SNAL $39.43
  • Revenue Next Year
  • MNOV N/A
  • SNAL $26.12
  • P/E Ratio
  • MNOV N/A
  • SNAL $35.99
  • Revenue Growth
  • MNOV N/A
  • SNAL 82.23
  • 52 Week Low
  • MNOV $1.12
  • SNAL $0.52
  • 52 Week High
  • MNOV $2.55
  • SNAL $3.42
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 53.13
  • SNAL 57.64
  • Support Level
  • MNOV $1.82
  • SNAL $2.61
  • Resistance Level
  • MNOV $1.97
  • SNAL $3.42
  • Average True Range (ATR)
  • MNOV 0.08
  • SNAL 0.34
  • MACD
  • MNOV 0.00
  • SNAL 0.03
  • Stochastic Oscillator
  • MNOV 62.50
  • SNAL 60.92

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About SNAL Snail Inc.

Snail Inc is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.

Share on Social Networks: